努特林-3a诱导KRAS突变/p53野生类型肺癌特异性甲状腺样细胞死亡,这取决于GFPT2
Dasom Kim1,2, Dongwha Min1,2, Joohee Kim3
1Department of Pathology, Korea University College of Medicine, 73, Goryeodae-Ro, Seongbuk-Gu, Seoul, 02841, South Korea.
Journal of experimental & clinical cancer research : CR
|December 14, 2023
概括
努特林-3a通过破坏KRAS-PI3K/Akt-mTOR通路,诱导KRAS突变非小细胞肺癌 (NSCLC) 的甲状腺样细胞死亡. 这为缺乏p53功能活性的NSCLC提供了潜在的替代疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症新陈代谢 癌症新陈代谢
背景情况:
- 瘤性KRAS突变驱动代谢重编程,并且在非小细胞肺癌 (NSCLC) 中普遍存在.
- 目前的KRAS抑制剂,如索托拉西布,仅限于KRAS-G12C突变和面临的抗药性.
- 对于针对NSCLC中其他KRAS突变的替代治疗策略有着至关重要的需要.
研究的目的:
- 研究针对KRAS突变NSCLC的新型治疗剂.
- 阐明KRAS突变NSCLC中由nutlin-3a诱导的细胞死亡的机制.
- 为了确定nutlin-3a疗效的预测生物标志物.
主要方法:
- 在体外分析NSCLC细胞系 (KRAS突变和野生类型).
- 检测细胞活力,增殖,细胞亡和形态 (MTT,细胞计数,FACS,全息学,共聚焦显微镜).
- RNA测序,qRT-PCR,西部涂抹和代谢物分析 (UHPLC-MS/MS) 以确定分子标和途径. 使用斑马鱼和老鼠异种移植模型的体内研究.
主要成果:
- 努特林-3a是一种MDM2抗剂,抑制了KRAS-PI3K/Akt-mTOR通路.
- 观察到自细胞和巨细胞与溶酶体的融合中断.
- 在KRAS突变/p53野生型NSCLC细胞中发现了依赖于Hexosamine生物合成途径GFPT2的甲状腺样细胞死亡.
结论:
- 努特林-3a显示出作为KRAS突变/p53野生型NSCLC的替代治疗剂的潜力.
- 准赫索胺生物合成途径可能是NSCLC治疗的可行策略.
- 需要进一步的研究来探索nutlin-3a在NSCLC中的临床适用性.
更多相关视频
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.8K
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10.2K
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
